Phillips 66 today released the following letter from Independent Director Bob Pease to the Company's shareholders: Shareholders of Phillips 66: I joined the Phillips 66 Board of Directors in February ...
58m
Received U.S. Food and Drug Administration (FDA) approval of Symvess™ (acellular tissue engineered vessel-tyod) for the treatment of extremity vascular trauma - - Commenced market launch and first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback